dc.date.accessioned | 2024-04-05T16:00:43Z | |
dc.date.available | 2024-04-05T16:00:43Z | |
dc.date.created | 2023-10-13T13:53:11Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Nieoczym, Dorota Banono, Nancy Saana Stępnik, Katarzyna Kaczor, Agnieszka A. Szybkowski, Przemysław Esguerra, Camila Kukula-Koch, Wirginia Gawel, Kinga Aurelia . In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice. International Journal of Molecular Sciences. 2023, 24(16) | |
dc.identifier.uri | http://hdl.handle.net/10852/110410 | |
dc.description.abstract | The aim of this study is to evaluate the anticonvulsant potential of schisandrin B, a main ingredient of Schisandra chinensis extracts. Schisandrin B showed anticonvulsant activity in the zebrafish larva pentylenetetrazole acute seizure assay but did not alter seizure thresholds in the intravenous pentylenetetrazole test in mice. Schisandrin B crosses the blood–brain barrier, which we confirmed in our in silico and in vivo analyses; however, the low level of its unbound fraction in the mouse brain tissue may explain the observed lack of anticonvulsant activity. Molecular docking revealed that the anticonvulsant activity of the compound in larval zebrafish might have been due to its binding to a benzodiazepine site within the GABAA receptor and/or the inhibition of the glutamate NMDA receptor. Although schisandrin B showed a beneficial anticonvulsant effect, toxicological studies revealed that it caused serious developmental impairment in zebrafish larvae, underscoring its teratogenic properties. Further detailed studies are needed to precisely identify the properties, pharmacological effects, and safety of schisandrin B. | |
dc.language | EN | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice | |
dc.title.alternative | ENEngelskEnglishIn Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice | |
dc.type | Journal article | |
dc.creator.author | Nieoczym, Dorota | |
dc.creator.author | Banono, Nancy Saana | |
dc.creator.author | Stępnik, Katarzyna | |
dc.creator.author | Kaczor, Agnieszka A. | |
dc.creator.author | Szybkowski, Przemysław | |
dc.creator.author | Esguerra, Camila | |
dc.creator.author | Kukula-Koch, Wirginia | |
dc.creator.author | Gawel, Kinga Aurelia | |
cristin.unitcode | 185,57,19,0 | |
cristin.unitname | Saarela group - Human immune disorders | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 2184506 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=International Journal of Molecular Sciences&rft.volume=24&rft.spage=&rft.date=2023 | |
dc.identifier.jtitle | International Journal of Molecular Sciences | |
dc.identifier.volume | 24 | |
dc.identifier.issue | 16 | |
dc.identifier.pagecount | 0 | |
dc.identifier.doi | https://doi.org/10.3390/ijms241612949 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 1661-6596 | |
dc.type.version | PublishedVersion | |
cristin.articleid | 12949 | |
dc.relation.project | NFR/187615 | |